1177 — Sino Biopharmaceutical Cashflow Statement
0.000.00%
- HK$122.39bn
- HK$127.39bn
- CNY28.87bn
- 92
- 29
- 93
- 86
Annual cashflow statement for Sino Biopharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5,013 | 18,573 | 5,779 | 5,410 | 5,277 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -600 | -13,112 | 566 | 786 | 946 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -698 | -1,066 | -1,088 | -1,177 | -901 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5,325 | 5,366 | 6,265 | 6,066 | 6,615 |
| Capital Expenditures | -1,424 | -1,714 | -1,243 | -1,068 | -960 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -6,421 | -802 | -2,827 | 311 | -749 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7,846 | -2,516 | -4,071 | -757 | -1,709 |
| Financing Cash Flow Items | -1,725 | -452 | -2,014 | -3,766 | -437 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,233 | -3,225 | -3,186 | -6,549 | -6,315 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.02 | -1,025 | -945 | -1,150 | -1,274 |